<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Achalasia: Pathogenesis, clinical manifestations, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Achalasia: Pathogenesis, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Achalasia: Pathogenesis, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stuart J Spechler, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nicholas J Talley, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 22, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Achalasia results from progressive degeneration of ganglion cells in the myenteric plexus in the esophageal wall, leading to failure of relaxation of the lower esophageal sphincter (LES), accompanied by a loss of peristalsis in the distal esophagus. This topic will review the etiology, pathogenesis, clinical manifestations, and diagnosis of achalasia. The management of achalasia is discussed separately. (See  <a class="medical medical_review" href="/d/html/2261.html" rel="external">"Overview of the treatment of achalasia"</a> and  <a class="medical medical_review" href="/d/html/2245.html" rel="external">"Pneumatic dilation and botulinum toxin injection for achalasia"</a> and  <a class="medical medical_review" href="/d/html/15060.html" rel="external">"Surgical myotomy for achalasia"</a>.)</p><p class="headingAnchor" id="H194739120"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Achalasia has been regarded as an uncommon disorder with an annual incidence of approximately 1.6 cases per 100,000 individuals and prevalence of 10 cases per 100,000 individuals [<a href="#rid1">1</a>]. Although epidemiologic data on achalasia are limited, its frequency appears to be rising, with one study suggesting that, from 2004 to 2014, the incidence and prevalence of achalasia in central Chicago were two- to threefold greater than estimates from earlier years would have predicted [<a href="#rid2">2</a>]. Males and females are affected with equal frequency. The disease can occur at any age, but onset before adolescence is rare. Achalasia is usually diagnosed in patients between the ages of 25 and 60 years. </p><p>Achalasia may occur in association with adrenal insufficiency and absent lacrimation in patients with triple A syndrome or Allgrove syndrome, a rare autosomal recessive genetic disorder [<a href="#rid3">3,4</a>].</p><p class="headingAnchor" id="H2107220471"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>The etiology of primary or idiopathic achalasia is unknown. Secondary achalasia is due to diseases that cause esophageal motor abnormalities similar or identical to those of primary achalasia  (<a class="graphic graphic_table graphicRef71111" href="/d/graphic/71111.html" rel="external">table 1</a>). In Chagas disease, which occurs predominantly in Central and South America, esophageal infection with the protozoan parasite <em>Trypanosoma cruzi</em> can result in loss of intramural ganglion cells, leading to aperistalsis and incomplete lower esophageal sphincter (LES) relaxation [<a href="#rid5">5</a>]. Other diseases that have been associated with achalasia-like motor abnormalities include amyloidosis, sarcoidosis, neurofibromatosis, eosinophilic esophagitis, multiple endocrine neoplasia type 2B, juvenile Sjögren’s disease, chronic idiopathic intestinal pseudo-obstruction, and Fabry disease [<a href="#rid6">6-12</a>]. (See  <a class="medical medical_review" href="/d/html/5700.html" rel="external">"Chagas gastrointestinal disease"</a>.)</p><p class="headingAnchor" id="H1453290685"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Achalasia has been assumed to result from inflammation and degeneration of neurons in the esophageal wall  (<a class="graphic graphic_figure graphicRef54138" href="/d/graphic/54138.html" rel="external">figure 1</a>) [<a href="#rid13">13</a>]. The cause of the inflammatory degeneration of neurons in primary achalasia is not known. The observations that achalasia is associated with variants in the HLA-DQ region and that affected patients often have circulating antibodies to enteric neurons suggest that achalasia is an autoimmune disorder [<a href="#rid14">14-16</a>]. Some investigators have proposed that the inflammatory attack on esophageal neurons in achalasia is triggered by an antibody response to viral infections (eg, herpes zoster, measles viruses), but data have been inconclusive [<a href="#rid17">17,18</a>]. A study evaluating T cells in patients with achalasia found reactivity to HSV-1, suggesting that achalasia may be triggered by HSV-1 infection [<a href="#rid19">19</a>]. A genetic predisposition to the inflammatory degeneration of ganglion cells in achalasia is suggested by its association with variants in the HLA-DQ region and by its occurrence in genetic syndromes such as Allgrove syndrome (see <a class="local">'Epidemiology'</a> above). It has also been suggested that there may be an allergy-driven form of achalasia [<a href="#rid20">20</a>]. </p><p>Histologic examination of the esophagus in patients with achalasia typically reveals decreased numbers of neurons (ganglion cells) in the myenteric plexuses, and the ganglion cells that remain often are surrounded by lymphocytes and, less prominently, by eosinophils [<a href="#rid21">21,22</a>]. This inflammatory degeneration preferentially involves the nitric oxide-producing, inhibitory neurons that affect the relaxation of esophageal smooth muscle; the cholinergic neurons that contribute to lower esophageal sphincter (LES) tone by causing smooth muscle contraction may be relatively spared [<a href="#rid23">23</a>]. In some patients, degenerative changes are also found in the ganglion cells of the dorsal motor nucleus of the vagus in the brainstem, and Wallerian degeneration has been observed in the vagal fibers that supply the esophagus  (<a class="graphic graphic_figure graphicRef54138" href="/d/graphic/54138.html" rel="external">figure 1</a>) [<a href="#rid24">24</a>]. However, the disordered motility that characterizes achalasia is believed to result primarily from the loss of inhibitory neurons within the wall of the esophagus itself. Loss of inhibitory innervation in the LES causes the basal sphincter pressure to rise and renders the sphincter muscle incapable of normal relaxation. In the smooth muscle portion of the esophageal body, the loss of inhibitory neurons results in aperistalsis [<a href="#rid25">25</a>]. The manifestations of achalasia depend on the degree and location of ganglion cell loss [<a href="#rid26">26</a>]. Loss of peristalsis in the distal esophagus and a failure of LES relaxation with swallowing both impair esophageal emptying; however, most of the symptoms and signs of achalasia are due primarily to the defect in LES relaxation (esophagogastric junction outflow obstruction).</p><p>In addition, patients with achalasia may also have a subtle defect in reflex relaxation of the upper esophageal sphincter (UES) [<a href="#rid27">27</a>]. The abrupt esophageal distention that results when gas from the stomach suddenly enters the esophagus normally triggers a reflex relaxation of the UES, thereby allowing the gas to escape through the mouth in the form of a belch. The UES belch reflex can be demonstrated experimentally by injecting air into the esophagus. In normal subjects, esophageal air injection causes UES relaxation that is accompanied by an audible belch. In patients with achalasia, however, air injected into the esophagus frequently causes a paradoxical increase in UES pressure without a belch. This abnormal reflex presumably results from the loss of inhibitory neurons, although the precise neural pathways that affect the reflex are not clear. The inability to burp in some patients with achalasia may contribute to the esophageal distention and chest pain that often accompany the disease. Patients with achalasia may also have impaired gastric relaxation [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H34211525"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Achalasia has an insidious onset, and disease progression is gradual. Patients typically experience symptoms for years prior to seeking medical attention. In one series of 87 consecutive patients with newly diagnosed achalasia, the mean duration of symptoms was 4.7 years prior to the diagnosis [<a href="#rid29">29</a>]. The delay in diagnosis was mainly due to misinterpretation of typical clinical features. Patients are often treated for other disorders including gastroesophageal reflux disease (GERD) before the diagnosis of achalasia is established [<a href="#rid30">30</a>]. </p><p class="headingAnchor" id="H198500171"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Dysphagia for solids (91 percent) and liquids (85 percent), and regurgitation of bland undigested food or saliva (76 to 91 percent) are the most frequent symptoms in patients with achalasia  (<a class="graphic graphic_figure graphicRef62139" href="/d/graphic/62139.html" rel="external">figure 2</a>) [<a href="#rid31">31,32</a>]. Regurgitation of retained material in the esophagus, especially while recumbent, may result in aspiration (8 percent). Patients may also induce vomiting to relieve a sensation of retrosternal fullness after a meal. Up to 85 percent of patients have difficulty belching, which may be due to a defect in relaxation of the upper esophageal sphincter (UES). Substernal chest pain and heartburn occur in approximately 40 to 60 percent of patients [<a href="#rid30">30</a>]. The etiology of chest pain in patients with achalasia is unclear as it does not always correlate with radiographic or manometric findings [<a href="#rid31">31</a>]. Chest pain is more common in younger patients and often fails to respond to treatment, but tends to diminish over the course of several years. (See <a class="local">'Pathogenesis'</a> above and  <a class="medical medical_review" href="/d/html/2262.html" rel="external">"Evaluation of the adult with chest pain of esophageal origin"</a>.)</p><p>Patients frequently report retrosternal burning discomfort similar to the heartburn typical of GERD. This may in fact be due to gastroesophageal reflux, or to direct irritation of the esophageal lining by food, pills, or lactate production by bacterial fermentation of retained carbohydrates [<a href="#rid33">33,34</a>]. Abnormal esophageal motor activity also might trigger the sensation of heartburn.</p><p>Patients may have hiccups due to obstruction of the distal esophagus [<a href="#rid35">35</a>]. In order to overcome the distal obstruction, affected patients eat more slowly and often adopt specific maneuvers such as lifting the neck or throwing the shoulders back in order to enhance esophageal emptying. Uncommonly, patients may present with a globus sensation. Weight loss is usually mild, although significant weight loss may be seen in some patients [<a href="#rid30">30</a>]. Rapid progression of dysphagia and profound weight loss are suggestive of pseudoachalasia due to a malignancy. (See  <a class="medical medical_review" href="/d/html/2240.html" rel="external">"Globus sensation", section on 'Clinical manifestations'</a> and <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H21967317"><span class="h2">Radiographic findings</span><span class="headingEndMark"> — </span>A plain radiograph of the chest may reveal widening of the mediastinum due to the dilated esophagus. The normal gastric air bubble may be absent due to the failure of lower esophageal sphincter (LES) relaxation that prevents swallowed air from entering the stomach  (<a class="graphic graphic_diagnosticimage graphicRef75115" href="/d/graphic/75115.html" rel="external">image 1</a>). Findings on <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram in patients with achalasia are discussed below. (See <a class="local">'Barium esophagram'</a> below.)</p><p class="headingAnchor" id="H2177558"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H3553861093"><span class="h2">Diagnostic approach</span><span class="headingEndMark"> — </span>Achalasia should be suspected in the following patients:</p><p class="bulletIndent1"><span class="glyph">●</span>Dysphagia to solids and liquids</p><p class="bulletIndent1"><span class="glyph">●</span>Heartburn unresponsive to a trial of proton pump inhibitor therapy </p><p class="bulletIndent1"><span class="glyph">●</span>Retained food in the esophagus on upper endoscopy</p><p class="bulletIndent1"><span class="glyph">●</span>Unusually increased resistance to passage of an endoscope through the esophagogastric junction</p><p></p><p>Esophageal manometry is required to establish the diagnosis  (<a class="graphic graphic_algorithm graphicRef110069" href="/d/graphic/110069.html" rel="external">algorithm 1</a>). Diagnostic manometric findings of achalasia are incomplete relaxation of the lower esophageal sphincter (LES; manifested as integrated relaxation pressure [IRP] above the upper limit of normal) and aperistalsis in the distal two-thirds of the esophagus. In patients with equivocal esophageal manometry results, <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram can help to assess esophageal emptying and esophagogastric junction morphology. In addition, measuring esophagogastric junction (EGJ) distensibility with the functional lumen imaging probe (FLIP) may help to clarify equivocal manometric findings, and this is discussed separately. (See  <a class="medical medical_review" href="/d/html/132586.html" rel="external">"Functional lumen imaging probe (FLIP) for adults with esophageal disorders"</a>.)</p><p>Endoscopic evaluation with upper gastrointestinal endoscopy should be performed in patients with suspected achalasia to exclude a malignancy at the esophagogastric junction that can mimic achalasia. (See <a class="local">'Esophageal manometry'</a> below and <a class="local">'Upper endoscopy'</a> below.)  </p><p>We perform additional evaluation with endoscopic ultrasonography and fine-needle aspiration to definitively rule out a malignancy at the esophagogastric junction in patients with any one of the following [<a href="#rid36">36,37</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical features suggestive of a malignancy (eg, symptoms of less than six months duration, new onset of dysphagia in patients &gt;60 years, rapid or marked weight loss)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal endoscopic evaluation (eg, unusually increased resistance to passage of endoscope through the esophagogastric junction or mucosal changes suggestive of a malignancy)</p><p></p><p>Our approach  (<a class="graphic graphic_algorithm graphicRef110069" href="/d/graphic/110069.html" rel="external">algorithm 1</a>) is largely consistent with guidelines from the American College of Gastroenterology and the American Gastroenterological Association [<a href="#rid37">37,38</a>]. </p><p class="headingAnchor" id="H386844726"><span class="h2">Esophageal manometry</span><span class="headingEndMark"> — </span>Both conventional and high-resolution manometry (HRM) can diagnose achalasia, but HRM is preferred and has essentially replaced conventional manometry entirely [<a href="#rid39">39,40</a>]. HRM is used to categorize achalasia into one of three distinctive subtypes, which can guide prognosis and management [<a href="#rid41">41-46</a>]. (See  <a class="medical medical_review" href="/d/html/17125.html" rel="external">"High resolution manometry", section on 'Disorders of EGJ outflow obstruction'</a> and  <a class="medical medical_review" href="/d/html/2261.html" rel="external">"Overview of the treatment of achalasia", section on 'Choice of treatment'</a>.)</p><p class="headingAnchor" id="H1015728645"><span class="h3">High-resolution manometry</span><span class="headingEndMark"> — </span>Achalasia is diagnosed on HRM by an elevated median IRP, which indicates impaired esophagogastric junction relaxation, and absence of normal peristalsis. The IRP is the median of the maximal relaxation pressures of the esophagogastric junction in four seconds during the 10-second window of esophagogastric junction relaxation that follows a swallow. The upper limit of normal median IRP value varies among manometry systems; for the most widely used system at this time, an elevated median IRP is identified as ≥15 mmHg. (See  <a class="medical medical_review" href="/d/html/17125.html" rel="external">"High resolution manometry", section on 'Integrated relaxation pressure (IRP)'</a>.)</p><p></p><p>According to the Chicago Classification (CC, version 4.0 [CC-4]) of patterns of esophageal pressurization on HRM, achalasia is subtyped into the following  (<a class="graphic graphic_figure graphicRef86439" href="/d/graphic/86439.html" rel="external">figure 3</a>) [<a href="#rid47">47</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type I (classic achalasia)</strong> – Swallowing results in no significant change in esophageal pressurization. By CC-4 criteria, type I achalasia has 100 percent failed peristalsis as indicated by a distal contractile integral (DCI, an index of the strength of distal esophageal contraction) &lt;100 mmHg·s·cm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type II</strong> – Swallowing results in simultaneous pressurization that spans the entire length of the esophagus. According to CC-4, type II achalasia has 100 percent failed peristalsis and pan-esophageal pressurization seen in ≥20 percent of swallows.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Type III (spastic achalasia)</strong> – Swallowing results in premature and often lumen-obliterating contractions or spasms. By CC-4 criteria, type III achalasia has no normal peristalsis and premature (spastic) contractions with distal latency &lt;4.5 seconds and DCI &gt;450 mmHg·s·cm seen in ≥20 percent of swallows.</p><p></p><p>These subtypes have important implications for management, and HRM is preferred over conventional manometry for the diagnosis of achalasia. (See  <a class="medical medical_review" href="/d/html/2261.html" rel="external">"Overview of the treatment of achalasia", section on 'Treatment approach'</a>.)</p><p class="headingAnchor" id="H4287909527"><span class="h2">Barium esophagram</span><span class="headingEndMark"> — </span>Findings on <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram that are suggestive of achalasia include:</p><p class="bulletIndent1"><span class="glyph">●</span>Dilation of the esophagus. In patients with late- or end-stage achalasia, the esophagus may appear significantly dilated (megaesophagus), angulated, and tortuous, giving it a sigmoid shape. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Narrow esophagogastric junction with "bird-beak" appearance caused by the persistently contracted LES  (<a class="graphic graphic_diagnosticimage graphicRef54252 graphicRef53672" href="/d/graphic/54252.html" rel="external">image 2A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aperistalsis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Delayed emptying of <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> [<a href="#rid48">48</a>]. </p><p></p><p>However, <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram is not a sensitive test for achalasia, as it may be interpreted as normal in up to one-third of patients [<a href="#rid30">30</a>]. In some patients, purposeless, spastic contractions are observed in the esophageal body. </p><p>A timed <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram (TBE) can be useful for documenting bolus retention for patients with untreated achalasia in addition to assessing response to treatment. To perform TBE, the patient drinks approximately 100 ml of low-density barium sulphate suspension, and oblique films are taken in the upright position at 1, 2, and 5 minutes after barium ingestion [<a href="#rid49">49</a>]. Most patients with untreated achalasia exhibit barium retention (measured by the height of the barium column) at one or more of these time points. After treatment, complete esophageal emptying at one minute post-barium ingestion is consistent with treatment success.</p><p class="headingAnchor" id="H2419126592"><span class="h2">Upper endoscopy</span><span class="headingEndMark"> — </span>Upper endoscopy may reveal a dilated esophagus that contains residual material, sometimes in large quantities. The appearance of the LES may range from normal to a thickened muscular ring with a rosette configuration on retroflexed view. In patients with achalasia, the LES typically does not open spontaneously to allow effortless passage of the endoscope into the stomach but, unlike obstruction caused by neoplasms or fibrotic strictures, the contracted LES can usually be traversed easily with gentle pressure on the endoscope. The esophageal mucosa usually appears normal in patients with achalasia [<a href="#rid30">30</a>]. Nonspecific changes that may be seen include erythema and ulceration due to inflammation, secondary to retained food and pills. Stasis may predispose to esophageal candidiasis, which may be seen as adherent whitish plaques. (See  <a class="medical medical_review" href="/d/html/2427.html" rel="external">"Esophageal candidiasis in adults", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H1610555655"><span class="h2">Endoscopic ultrasound</span><span class="headingEndMark"> — </span>Findings of achalasia on endoscopic ultrasound (EUS) can include a thickened circular muscle layer at the LES and through the smooth muscle esophagus. Although the accuracy of EUS in distinguishing achalasia from pseudoachalasia has not been established, EUS is useful for characterizing tumors of the distal esophagus and gastric cardia [<a href="#rid50">50</a>]. EUS findings of marked (&gt;10 mm) and/or asymmetric esophageal wall thickening are suggestive of an underlying malignancy that may be confirmed by fine-needle aspiration. (See  <a class="medical medical_review" href="/d/html/2656.html" rel="external">"Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract", section on 'Upper GI tract lesions'</a>.)</p><p class="headingAnchor" id="H2157103540"><span class="h2">Functional lumen imaging probe</span><span class="headingEndMark"> — </span>Functional lumen imaging probe (FLIP) is a catheter-based instrument with an attached, fluid-filled balloon that surrounds a series of impedance planimetry electrodes. The FLIP catheter is passed into the esophagus, and it displays the diameter of various esophageal segments in real-time images. In addition, FLIP provides real-time information about the distensibility of the esophageal segments in the form of a distensibility index, and information about esophageal motility in the form of FLIP topography. In achalasia, FLIP reveals a narrowed esophagogastric junction segment that has a low distensibility index, and inflation of the FLIP balloon results in abnormal or no esophageal contractions. FLIP may provide useful data to establish the diagnosis of achalasia in equivocal cases [<a href="#rid51">51</a>]. (See  <a class="medical medical_review" href="/d/html/132586.html" rel="external">"Functional lumen imaging probe (FLIP) for adults with esophageal disorders"</a>.)</p><p class="headingAnchor" id="H2137212199"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of achalasia is established by the presence of aperistalsis in the distal two-thirds of the esophagus and incomplete lower esophageal sphincter (LES) relaxation on manometry (elevated median integrated relaxation pressure [IRP] by high-resolution manometry [HRM]). In patients with typical achalasia symptoms (dysphagia to solids and liquids and regurgitation of bland undigested food or saliva) and equivocal manometric findings, the diagnosis is supported by aperistalsis, dilation of the esophagus, narrow esophagogastric junction, and poor emptying on <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram. Pseudoachalasia due to cancer at the esophagogastric junction should be excluded by endoscopic evaluation as discussed above. (See <a class="local">'Diagnostic approach'</a> above.)</p><p class="headingAnchor" id="H8"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Achalasia may be misdiagnosed as gastroesophageal reflux disease (GERD), especially in patients with chest pain of a burning quality typical of heartburn. The differential diagnosis of achalasia also includes other esophageal motility disorders and pseudoachalasia due to a malignancy. The differential diagnosis of dysphagia is discussed in detail, separately. (See  <a class="medical medical_review" href="/d/html/2241.html" rel="external">"Approach to the evaluation of dysphagia in adults", section on 'Symptom-based differential diagnosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastroesophageal reflux disease</strong> – In patients with GERD, regurgitated food is typically sour tasting due to the presence of gastric acid. In contrast, in patients with achalasia, food and saliva are regurgitated from the esophagus and are therefore bland. Esophageal manometry is diagnostic of achalasia. Unlike the incomplete lower esophageal sphincter (LES) relaxation and aperistalsis that characterize achalasia, patients with GERD often have nonspecific manometric findings including ineffective esophageal motility and hypotensive LES. (See <a class="local">'Esophageal manometry'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudoachalasia</strong> – Malignancy can cause pseudoachalasia either by invading the esophageal neural plexuses directly (eg, adenocarcinoma of the esophagogastric junction) or through the release of uncharacterized humoral factors that disrupt esophageal function as part of a paraneoplastic syndrome. In addition to gastric carcinoma, other tumors that can produce the syndrome include cancer of the esophagus, carcinoma of the lung, lymphoma, and pancreatic carcinoma [<a href="#rid52">52,53</a>]. Patients with pseudoachalasia can have the same manometric findings as those with achalasia but can be differentiated by upper endoscopy and endoscopic ultrasound (EUS). (See <a class="local">'Esophageal manometry'</a> above and <a class="local">'Upper endoscopy'</a> above and <a class="local">'Endoscopic ultrasound'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other esophageal motility disorders</strong> – Patients with distal esophageal spasm and jackhammer esophagus may also present with dysphagia to solids and liquids. Esophageal manometry testing can distinguish achalasia from these esophageal motility disorders as LES relaxation (integrated relaxation pressure [IRP]) is normal in these conditions. (See <a class="local">'Esophageal manometry'</a> above and  <a class="medical medical_review" href="/d/html/2256.html" rel="external">"Distal esophageal spasm and hypercontractile esophagus"</a>.)</p><p></p><p class="headingAnchor" id="H194739362"><span class="h1">NATURAL HISTORY AND PROGNOSIS</span></p><p class="headingAnchor" id="H21967835"><span class="h2">Disease course</span><span class="headingEndMark"> — </span>Without treatment, patients with achalasia can develop progressive dilation of the esophagus. Late- or end-stage achalasia is characterized by esophageal tortuosity, angulation, and severe dilation or megaesophagus (diameter &gt;6 cm). Approximately 10 to 15 percent of patients who have undergone treatment for achalasia will develop late- or end-stage achalasia, and up to 5 percent of patients in some series require esophagectomy [<a href="#rid54">54,55</a>].</p><p class="headingAnchor" id="H21967828"><span class="h2">Cancer risk</span><span class="headingEndMark"> — </span>Patients with achalasia are at increased risk for developing esophageal cancer; however, the absolute risk for esophageal cancer is low [<a href="#rid56">56-61</a>]. In one study in which 448 patients with achalasia were followed for a median of 9.6 years, esophageal cancer developed in 15 patients (3.3 percent) after mean symptom duration of 13 years [<a href="#rid59">59</a>]. While the risk of esophageal cancer was increased 28-fold (95% CI 17-46) as compared with controls, the annual incidence of esophageal cancer was only 0.34 percent (95% CI 0.20-0.56).</p><p>Esophageal cancer is typically squamous cell type, although some studies have also demonstrated an increased risk of esophageal adenocarcinoma. Endoscopic surveillance in patients with achalasia is controversial and is not routinely recommended. In a population-based study in Sweden in which 1062 patients with achalasia were followed for up to 24 years, the risk of esophageal cancer was increased 16-fold (95% CI 8.8-28.3) above that of population controls [<a href="#rid56">56</a>]. Esophageal cancer was diagnosed an average of 14 years following the diagnosis of achalasia. It was estimated that annual surveillance endoscopy after the first year would be required in 406 males and 2200 females to detect one cancer. (See  <a class="medical medical_review" href="/d/html/2261.html" rel="external">"Overview of the treatment of achalasia", section on 'Surveillance'</a>.)</p><p>There are limited long-term data on the incidence of esophageal cancer following a Heller myotomy for achalasia. However, available data suggest that patients remain at increased risk for esophageal cancer [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/d/html/15060.html" rel="external">"Surgical myotomy for achalasia", section on 'Other complications'</a>.)</p><p class="headingAnchor" id="H1066302936"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118140.html" rel="external">"Society guideline links: Achalasia"</a>.)</p><p class="headingAnchor" id="H606595477"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/16153.html" rel="external">"Patient education: Achalasia (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/15732.html" rel="external">"Patient education: Upper endoscopy (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (See  <a class="medical medical_patient" href="/d/html/1998.html" rel="external">"Patient education: Achalasia (Beyond the Basics)"</a>.)</p><p></p><p class="headingAnchor" id="H21885408"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis </strong>–<strong> </strong>Achalasia is thought to result from progressive degeneration of ganglion cells in the myenteric plexus in the esophageal wall leading to failure of relaxation of the lower esophageal sphincter (LES) accompanied by a loss of peristalsis in the distal esophagus. The etiology of primary or idiopathic achalasia is unknown. Secondary achalasia is due to diseases that cause esophageal motor abnormalities similar or identical to those of primary achalasia  (<a class="graphic graphic_table graphicRef71111" href="/d/graphic/71111.html" rel="external">table 1</a>). (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>–<strong> </strong>Achalasia has been regarded as an uncommon disorder with an annual incidence of approximately 1.6 cases per 100,000 individuals and prevalence of 10 cases per 100,000 individuals. Achalasia can occur at any age, but is usually diagnosed in patients between 25 and 60 years. Males and females are affected with equal frequency. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>–<strong> </strong>Dysphagia for solids and liquids and regurgitation of bland undigested food or saliva are the most frequent symptoms in patients with achalasia. Other symptoms include chest pain, heartburn, and difficulty belching. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic approach</strong> – Achalasia should be suspected in the following patients (see <a class="local">'Diagnostic approach'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dysphagia to solids and liquids</p><p class="bulletIndent2"><span class="glyph">•</span>Heartburn unresponsive to a trial of proton pump inhibitor therapy for four weeks</p><p class="bulletIndent2"><span class="glyph">•</span>Retained food in the esophagus on upper endoscopy</p><p class="bulletIndent2"><span class="glyph">•</span>Unusually increased resistance to passage of an endoscope through the esophagogastric junction</p><p></p><p class="bulletIndent1">Esophageal manometry is required to establish the diagnosis  (<a class="graphic graphic_algorithm graphicRef110069" href="/d/graphic/110069.html" rel="external">algorithm 1</a>). Achalasia is diagnosed on high-resolution manometry (HRM) by an elevated median integrated relaxation pressure (IRP) and absence of normal peristalsis. (See <a class="local">'Esophageal manometry'</a> above.)</p><p></p><p class="bulletIndent1">In patients with equivocal esophageal manometry results, <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> esophagram should be performed to assess esophageal emptying and esophagogastric junction morphology. Upper endoscopy should be performed in all patients with achalasia to exclude an esophagogastric malignancy.</p><p></p><p class="bulletIndent1">We perform additional evaluation with endoscopic ultrasound (EUS) and fine-needle aspiration to definitively rule out a malignancy at the esophagogastric junction in patients with any one of the following: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinical features suggestive of a malignancy (eg, symptoms of less than six months duration, new onset of dysphagia in patients &gt;60 years, rapid or marked weight loss)</p><p class="bulletIndent2"><span class="glyph">•</span>Atypical endoscopic evaluation (eg, unusually increased resistance to passage of endoscope or mucosal changes suggestive of a malignancy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Natural history and prognosis</strong> – Patients with achalasia are at an increased risk for developing esophageal cancer; however, the absolute risk is low. Surveillance for esophageal cancer is therefore not routinely performed for patients with achalasia. (See <a class="local">'Cancer risk'</a> above and  <a class="medical medical_review" href="/d/html/2261.html" rel="external">"Overview of the treatment of achalasia", section on 'Surveillance'</a>.)</p><p></p><p class="bulletIndent1">Without treatment, patients with achalasia can develop progressive dilation of the esophagus. Late- or end-stage achalasia is characterized by esophageal tortuosity, angulation, and severe dilation or megaesophagus (diameter &gt;6 cm). Approximately 10 to 15 percent of patients who have undergone treatment for achalasia will develop late- or end-stage achalasia, and up to 5 percent of patients may require esophagectomy. (See <a class="local">'Disease course'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010; 22:e256.</a></li><li><a class="nounderline abstract_t">Samo S, Carlson DA, Gregory DL, et al. Incidence and Prevalence of Achalasia in Central Chicago, 2004-2014, Since the Widespread Use of High-Resolution Manometry. Clin Gastroenterol Hepatol 2017; 15:366.</a></li><li><a class="nounderline abstract_t">Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978; 1:1284.</a></li><li><a class="nounderline abstract_t">Verma S, Brown S, Dakkak M, Bennett JR. Association of adult achalasia and alacrima. Dig Dis Sci 1999; 44:876.</a></li><li><a class="nounderline abstract_t">de Oliveira RB, Rezende Filho J, Dantas RO, Iazigi N. The spectrum of esophageal motor disorders in Chagas' disease. Am J Gastroenterol 1995; 90:1119.</a></li><li><a class="nounderline abstract_t">Costigan DJ, Clouse RE. Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig Dis Sci 1983; 28:763.</a></li><li><a class="nounderline abstract_t">Dufresne CR, Jeyasingham K, Baker RR. Achalasia of the cardia associated with pulmonary sarcoidosis. Surgery 1983; 94:32.</a></li><li><a class="nounderline abstract_t">Foster PN, Stewart M, Lowe JS, Atkinson M. Achalasia like disorder of the oesophagus in von Recklinghausen's neurofibromatosis. Gut 1987; 28:1522.</a></li><li><a class="nounderline abstract_t">Cuthbert JA, Gallagher ND, Turtle JR. Colonic and oesophageal disturbance in a patient with multiple endocrine neoplasia, type 2b. Aust N Z J Med 1978; 8:518.</a></li><li><a class="nounderline abstract_t">Similä S, Kokkonen J, Kaski M. Achalasia sicca--juvenile Sjögren's syndrome with achalasia and gastric hyposecretion. Eur J Pediatr 1978; 129:175.</a></li><li><a class="nounderline abstract_t">Schuffler MD. Chronic intestinal pseudo-obstruction syndromes. Med Clin North Am 1981; 65:1331.</a></li><li><a class="nounderline abstract_t">Roberts DH, Gilmore IT. Achalasia in Anderson-Fabry's disease. J R Soc Med 1984; 77:430.</a></li><li><a class="nounderline abstract_t">Reynolds JC, Parkman HP. Achalasia. Gastroenterol Clin North Am 1989; 18:223.</a></li><li><a class="nounderline abstract_t">Wong RK, Maydonovitch CL, Metz SJ, Baker JR Jr. Significant DQw1 association in achalasia. Dig Dis Sci 1989; 34:349.</a></li><li><a class="nounderline abstract_t">Verne GN, Sallustio JE, Eaker EY. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig Dis Sci 1997; 42:307.</a></li><li><a class="nounderline abstract_t">Verne GN, Hahn AB, Pineau BC, et al. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology 1999; 117:26.</a></li><li><a class="nounderline abstract_t">Niwamoto H, Okamoto E, Fujimoto J, et al. Are human herpes viruses or measles virus associated with esophageal achalasia? Dig Dis Sci 1995; 40:859.</a></li><li><a class="nounderline abstract_t">Birgisson S, Galinski MS, Goldblum JR, et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997; 42:300.</a></li><li><a class="nounderline abstract_t">Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol 2008; 103:1598.</a></li><li><a class="nounderline abstract_t">Spechler SJ, Konda V, Souza R. Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders? Am J Gastroenterol 2018; 113:1594.</a></li><li><a class="nounderline abstract_t">Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994; 18:327.</a></li><li><a class="nounderline abstract_t">Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996; 111:648.</a></li><li><a class="nounderline abstract_t">Holloway RH, Dodds WJ, Helm JF, et al. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986; 90:924.</a></li><li><a class="nounderline abstract_t">Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 1984; 87:848.</a></li><li><a class="nounderline abstract_t">Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA 2015; 313:1841.</a></li><li><a class="nounderline abstract_t">Sodikoff JB, Lo AA, Shetuni BB, et al. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil 2016; 28:139.</a></li><li><a class="nounderline abstract_t">Massey BT, Hogan WJ, Dodds WJ, Dantas RO. Alteration of the upper esophageal sphincter belch reflex in patients with achalasia. Gastroenterology 1992; 103:1574.</a></li><li><a class="nounderline abstract_t">Mearin F, Papo M, Malagelada JR. Impaired gastric relaxation in patients with achalasia. Gut 1995; 36:363.</a></li><li><a class="nounderline abstract_t">Eckardt VF, Köhne U, Junginger T, Westermeier T. Risk factors for diagnostic delay in achalasia. Dig Dis Sci 1997; 42:580.</a></li><li><a class="nounderline abstract_t">Howard PJ, Maher L, Pryde A, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992; 33:1011.</a></li><li><a class="nounderline abstract_t">Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 1999; 116:1300.</a></li><li><a class="nounderline abstract_t">Fisichella PM, Raz D, Palazzo F, et al. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia. World J Surg 2008; 32:1974.</a></li><li><a class="nounderline abstract_t">Spechler SJ, Souza RF, Rosenberg SJ, et al. Heartburn in patients with achalasia. Gut 1995; 37:305.</a></li><li><a class="nounderline abstract_t">Burke CA, Achkar E, Falk GW. Effect of pneumatic dilation on gastroesophageal reflux in achalasia. Dig Dis Sci 1997; 42:998.</a></li><li><a class="nounderline abstract_t">Seeman H, Traube M. Hiccups and achalasia. Ann Intern Med 1991; 115:711.</a></li><li><a class="nounderline abstract_t">Carter M, Deckmann RC, Smith RC, et al. Differentiation of achalasia from pseudoachalasia by computed tomography. Am J Gastroenterol 1997; 92:624.</a></li><li><a class="nounderline abstract_t">Vaezi MF, Pandolfino JE, Yadlapati RH, et al. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. Am J Gastroenterol 2020; 115:1393.</a></li><li><a class="nounderline abstract_t">Spechler SJ. American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999; 117:229.</a></li><li><a class="nounderline abstract_t">Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol 2008; 103:27.</a></li><li><a class="nounderline abstract_t">Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol 2008; 42:627.</a></li><li><a class="nounderline abstract_t">Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008; 135:1526.</a></li><li><a class="nounderline abstract_t">Roman S, Zerbib F, Quenehervé L, et al. The Chicago classification for achalasia in a French multicentric cohort. Dig Liver Dis 2012; 44:976.</a></li><li><a class="nounderline abstract_t">Salvador R, Costantini M, Zaninotto G, et al. The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia. J Gastrointest Surg 2010; 14:1635.</a></li><li><a class="nounderline abstract_t">Pratap N, Reddy DN. Can achalasia subtyping by high-resolution manometry predict the therapeutic outcome of pneumatic balloon dilatation?: author's reply. J Neurogastroenterol Motil 2011; 17:205.</a></li><li><a class="nounderline abstract_t">Min M, Peng LH, Yang YS, et al. Characteristics of achalasia subtypes in untreated Chinese patients: a high-resolution manometry study. J Dig Dis 2012; 13:504.</a></li><li><a class="nounderline abstract_t">Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001; 49:145.</a></li><li><a class="nounderline abstract_t">Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©. Neurogastroenterol Motil 2021; 33:e14058.</a></li><li><a class="nounderline abstract_t">Rohof WO, Lei A, Boeckxstaens GE. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol 2013; 108:49.</a></li><li><a class="nounderline abstract_t">Neyaz Z, Gupta M, Ghoshal UC. How to perform and interpret timed barium esophagogram. J Neurogastroenterol Motil 2013; 19:251.</a></li><li><a class="nounderline abstract_t">Miller LS, Liu JB, Barbarevech CA, et al. High-resolution endoluminal sonography in achalasia. Gastrointest Endosc 1995; 42:545.</a></li><li><a class="nounderline abstract_t">Triggs JR, Carlson DA, Beveridge C, et al. Functional Luminal Imaging Probe Panometry Identifies Achalasia-Type Esophagogastric Junction Outflow Obstruction. Clin Gastroenterol Hepatol 2020; 18:2209.</a></li><li><a class="nounderline abstract_t">Kahrilas PJ, Kishk SM, Helm JF, et al. Comparison of pseudoachalasia and achalasia. Am J Med 1987; 82:439.</a></li><li><a class="nounderline abstract_t">Campos CT, Ellis FH Jr, LoCicero J 3rd. Pseudoachalasia: a report of two cases with comments on possible causes and diagnosis. Dis Esophagus 1997; 10:220.</a></li><li><a class="nounderline abstract_t">Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation. Eur J Gastroenterol Hepatol 2008; 20:956.</a></li><li><a class="nounderline abstract_t">Vela MF, Richter JE, Wachsberger D, et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol 2004; 99:1029.</a></li><li><a class="nounderline abstract_t">Sandler RS, Nyrén O, Ekbom A, et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 1995; 274:1359.</a></li><li><a class="nounderline abstract_t">Csendes A, Braghetto I, Burdiles P, et al. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann Surg 2006; 243:196.</a></li><li><a class="nounderline abstract_t">Streitz JM Jr, Ellis FH Jr, Gibb SP, Heatley GM. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg 1995; 59:1604.</a></li><li><a class="nounderline abstract_t">Leeuwenburgh I, Scholten P, Alderliesten J, et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol 2010; 105:2144.</a></li><li><a class="nounderline abstract_t">Zendehdel K, Nyrén O, Edberg A, Ye W. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol 2011; 106:57.</a></li><li><a class="nounderline abstract_t">Zaninotto G, Rizzetto C, Zambon P, et al. Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J Surg 2008; 95:1488.</a></li></ol></div><div id="topicVersionRevision">Topic 2268 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20465592" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Achalasia: incidence, prevalence and survival. A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27581064" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Incidence and Prevalence of Achalasia in Central Chicago, 2004-2014, Since the Widespread Use of High-Resolution Manometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/78049" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10235590" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Association of adult achalasia and alacrima.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7611209" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The spectrum of esophageal motor disorders in Chagas' disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6872809" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6857509" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Achalasia of the cardia associated with pulmonary sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3123332" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Achalasia like disorder of the oesophagus in von Recklinghausen's neurofibromatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33647" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Colonic and oesophageal disturbance in a patient with multiple endocrine neoplasia, type 2b.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/699923" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Achalasia sicca--juvenile Sjögren's syndrome with achalasia and gastric hyposecretion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6799718" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Chronic intestinal pseudo-obstruction syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6427465" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Achalasia in Anderson-Fabry's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2668168" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2920639" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Significant DQw1 association in achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9052511" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10381906" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Association of HLA-DR and -DQ alleles with idiopathic achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7720482" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Are human herpes viruses or measles virus associated with esophageal achalasia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9052510" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Achalasia is not associated with measles or known herpes and human papilloma viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18557707" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30315308" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8141427" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Achalasia. A morphologic study of 42 resected specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8780569" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Histopathologic features in esophagomyotomy specimens from patients with achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3949120" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6088351" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25965233" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Achalasia: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26542087" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Histopathologic patterns among achalasia subtypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1426877" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Alteration of the upper esophageal sphincter belch reflex in patients with achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7698693" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Impaired gastric relaxation in patients with achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9073142" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Risk factors for diagnostic delay in achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1398223" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10348812" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Chest pain in achalasia: patient characteristics and clinical course.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18575930" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical, radiological, and manometric profile in 145 patients with untreated achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7590421" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Heartburn in patients with achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9149054" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of pneumatic dilation on gastroesophageal reflux in achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1929039" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hiccups and achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9128311" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Differentiation of achalasia from pseudoachalasia by computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32773454" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : ACG Clinical Guidelines: Diagnosis and Management of Achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10381932" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17900331" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18364587" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Esophageal motility disorders in terms of pressure topography: the Chicago Classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18722376" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Achalasia: a new clinically relevant classification by high-resolution manometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22938702" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The Chicago classification for achalasia in a French multicentric cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20830530" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21603005" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Can achalasia subtyping by high-resolution manometry predict the therapeutic outcome of pneumatic balloon dilatation?: author's reply.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22988923" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Characteristics of achalasia subtypes in untreated Chinese patients: a high-resolution manometry study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11413123" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Classification of oesophageal motility abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33373111" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23007004" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23667757" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : How to perform and interpret timed barium esophagogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8674925" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : High-resolution endoluminal sonography in achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31778806" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Functional Luminal Imaging Probe Panometry Identifies Achalasia-Type Esophagogastric Junction Outflow Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3548347" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Comparison of pseudoachalasia and achalasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9280084" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Pseudoachalasia: a report of two cases with comments on possible causes and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18787460" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15180721" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7563560" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The risk of esophageal cancer in patients with achalasia. A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16432352" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7771859" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20588263" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Long-term esophageal cancer risk in patients with primary achalasia: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21212754" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18991316" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Long-term outcome and risk of oesophageal cancer after surgery for achalasia.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
